AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9005798
Drug: Ofloxacin used
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin used orally in the form of tablets in a dose of 200 mg once a day in the morning for 5 to 7 days.
Trial: 9005798
Drug: Ofloxacin used
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin used in the same dosage but in combination with some other antibiotics.
Trial: 9005798
Drug: Antibiotics except
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics except for ofloxacin.
Trial: 1752022
Drug: High tidal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High tidal volume (HVT, 12.7 ml.kg‐1) ventilation
Trial: 1752022
Drug: Conventional tidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional tidal volume (CVT, 7.5 ml.kg‐1) ventilation
Trial: 6753115
Drug: Pirenzepine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (100 mg/day for six weeks)
Trial: 26852726
Drug: Oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral moxifloxacin (400 mg on days 1-7)
Trial: 26852726
Drug: Oral solithromycin
RxNorm normalized name: roxithromycin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral solithromycin
Trial: 17502431
Drug: Triazolam (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.25, 0.5, and 0.75 mg)
Trial: 10445371
Drug: Zaleplon (25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zaleplon (25, 50, and 75 mg)
Trial: 29746955
Drug: Micafungin 100
RxNorm normalized name: micafungin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin 100 mg intravenously daily
Trial: 29746955
Drug: Posaconazole suspension
RxNorm normalized name: Posaconazole
DrugBank: Posaconazole (DB01263)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Posaconazole suspension 400 mg orally twice daily
Trial: 21518127
Drug: 20 IU
RxNorm normalized name: Calcium/Phosphorus/Vitamin D 105 MG-81 MG-120 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 IU oxytocin dissolved in 30 mL saline (n=26)
Trial: 21518127
Drug: Ergometrine 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ergometrine 0.2 mg dissolved in 30 mL saline (n=27)
Trial: 21518127
Drug: Misoprostol 800
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol 800 µg dissolved in 30 mL saline (n=25)
Trial: 17086737
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg of oral midazolam 20 minutes prior to dental treatment
Trial: 3064641
Drug: Bedtime ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bedtime ethanol (2 ml/kg of 100 proof vodka mixed in orange juice)
Trial: 29761006
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium valproate, 30 mg/kg as loading dose and then 4-8 mg/kg every 8 hr as maintenance regimen
Trial: 29761006
Drug: Intravenous phenytoin
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous phenytoin (IV PHT) 20 mg/kg as loading dose and then 1.5 mg/kg for 8 hr as maintenance therapy
Trial: 22963271
Drug: Homeopathic combination
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic combination remedy dysto-loges S
Trial: 20636249
Drug: Brief individual
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief individual cognitive behavioral counseling comprising three weekly 1 hour sessions (n = 33)
Trial: 15998903
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg daily)
Trial: 17389658
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once-weekly (QW)
Trial: 210379
Drug: Neomycin-polymyxin irrigant
RxNorm normalized name: neomycin / polymyxin B Irrigation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neomycin-polymyxin irrigant administered through closed urinary catheters
Trial: 29171646
Drug: fast rocuronium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fast rocuronium injection with saline
Trial: 29171646
Drug: slow rocuronium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: slow rocuronium injection with remifentanil
Trial: 29171646
Drug: fast rocuronium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fast rocuronium injection with remifentanil
Trial: 23836616
Drug: Systematic smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systematic smoking ascertainment and default provision of behavioural support and cessation pharmacotherapy during hospital stay; follow-up and referral to community services after discharge.
Trial: 15193678
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg once daily
Trial: 25849228
Drug: Oseltamivir treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir treatment
Trial: 11052557
Drug: Active supplements
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active supplements
Trial: 31902864
Drug: Placebo supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplements
Trial: 8257409
Drug: High-dose naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose naltrexone
Trial: 2859043
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg atenolol
Trial: 31095810
Drug: Diluted single-phase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diluted single-phase (DS; 1.6 ml/s)
Trial: 31095810
Drug: Diluted biphasic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diluted biphasic (DB; 9 ml @ 3.3 ml/s, 29 ml @ 1.4 ml/s)
Trial: 25082346
Drug: Dasatinib 100
RxNorm normalized name: dasatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib 100 mg QD
Trial: 19583071
Drug: Gabapentin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (900 mg)
Trial: 20175608
Drug: Structural Ecosystems
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structural Ecosystems Therapy (SET)
Trial: 20490354
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment for 4 weeks
Trial: 7387336
Drug: Beta-endorphin treatment
RxNorm normalized name: beta-endorphin human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-endorphin treatment
Trial: 20974325
Drug: Test tablet
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test tablet (20 mg)
Trial: 10228298
Drug: Soy formula
RxNorm normalized name: Nursoy Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy formula (579 31 mL/d)
Trial: 1778087
Drug: Furosemide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (20 mg) - Spironolactone (100 mg) formulation 1
Trial: 1778087
Drug: Furosemide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (20 mg) - Spironolactone (100 mg) formulation 2
Trial: 20093332
Drug: Conventional wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional wound treatment (Control)
Trial: 3300383
Drug: Mezlocillin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mezlocillin (2 doses)
Trial: 8480929
Drug: Mezlocillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mezlocillin (3 doses)
Trial: 30309244
Drug: TPH2 rs4570625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPH2 rs4570625 (T-allele carriers: G/T or T/T genotypes)
Trial: 16024973
Drug: G/G homozygotes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G/G homozygotes
Trial: 28489001
Drug: Noradrenergic blockade
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenergic blockade (40 mg propranolol)
Trial: 28489001
Drug: Dopamine D2/3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine D2/3 receptor blockade (400 mg amisulpride)
Trial: 22966986
Drug: ABT-102 (2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-102 (2, 6, 18, 30 and 40 mg single dose; 2, 4 and 8 mg twice daily for 7 days; 1, 2 and 4 mg twice daily for 7 days)
Trial: 8988926
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (15 mg)
Trial: 3631029
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg trimoprostil
Trial: 18208909
Drug: Reboxetine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (7 days treatment)
Trial: 16826486
Drug: BRV-TV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRV-TV vaccine
Trial: 10426173
Drug: RRV-TV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV-TV vaccine
Trial: 8165742
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg body weight over 3 days)
Trial: 8165742
Drug: Sulfadoxine/pyrimethamine (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine/pyrimethamine (standard doses)
Trial: 22072492
Drug: Panobinostat (LBH589),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panobinostat (LBH589), oral administration
Trial: 2312778
Drug: Metoprolol controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol controlled release tablets 100 mg CR/ZOK
Trial: 2312778
Drug: Metoprolol conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol conventional tablets 100 mg (CT)
Trial: 2312778
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg (ATL)
Trial: 1221098
Drug: Antifibrinolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antifibrinolytic therapy
Trial: 7000220
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antifibrinolytic therapy)
Trial: 27546524
Drug: Topical estriol
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical estriol treatment (0.5 mg estriol ovules for 8 weeks)
Trial: 27546524
Drug: Topical estriol
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical estriol treatment
Trial: 23195924
Drug: Individualized methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized methadone dosages over 100 mg/day with voucher-based cocaine-targeted contingency management (CM)
Trial: 23195924
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose increase from 70 mg/day to 100 mg/day
Trial: 21950153
Drug: New pharmaceutical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New pharmaceutical equivalent tablet formulation containing 500 mg of SAQ mesylate
Trial: 21950153
Drug: Innovator film
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Innovator film coated tablet formulation
Trial: 8482988
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg Statil (Ponalrestat)
Trial: 3691679
Drug: Nebulised salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised salbutamol (2.5 mg)
Trial: 21621801
Drug: Low-fructose diet
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-fructose diet (<20 g/d)
Trial: 11122832
Drug: Targeted alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted alpha particle therapy
Trial: 3569230
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g of glucose (trial G)
Trial: 3569230
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml of a sweetened placebo (trial C)
Trial: 29445030
Drug: Cabozantinib 60
RxNorm normalized name: cabozantinib 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabozantinib 60 mg orally daily
Trial: 30587441
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel 80 mg/m2 given 3 out of 4 weeks
Trial: 27487463
Drug: Ofloxacin administered
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin administered one hour before IVI (every 15 minutes)
Trial: 7633476
Drug: Combination Ho/Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Ho/Nd:YAG laser ablation
Trial: 11252642
Drug: Lithium therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium therapy
Trial: 31201188
Drug: 6 weeks
RxNorm normalized name: perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 6 weeks treatment with oral doxycycline
Trial: 31201188
Drug: 2 weeks
RxNorm normalized name: Rykindo, 25 mg/2 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 weeks treatment with oral doxycycline
Trial: 20220046
Drug: Integrated glucose-insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated glucose-insulin model
Trial: 11327626
Drug: 24h sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24h sodium excretion in premenopausal women
Trial: 11327626
Drug: Cross-center correlation
RxNorm normalized name: Red Cross Canker Sore
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cross-center correlation analyses of 24h sodium excretion
Trial: 8934963
Drug: Triazolam (0.375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.375 or 0.50 mg)
Trial: 31161583
Drug: Internal medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal medicine residents and attending physicians
Trial: 26853137
Drug: Continue antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue antihypertensive drugs
Trial: 18165592
Drug: Morphine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine alone (1.5 mg) - Group M
Trial: 17314337
Drug: Combination regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination regimen of salmeterol (50 microg) plus fluticasone propionate (500 microg) twice daily
Trial: 9457400
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous rIL-2 (720,000 IU/kg)
Trial: 9457400
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous rIL-2 (72,000 IU/kg)
Trial: 9457400
Drug: Subcutaneous outpatient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous outpatient rIL-2 (week 1: 250,000 IU/kg/day for 5 of 7 days; weeks 2-6: 125,000 IU/kg/day for 5 of 7 days)
Trial: 8032699
Drug: 5‐HT3 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐HT3 receptor antagonist (5‐HT3 RA)
Trial: 3583492
Drug: Sulglycotide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulglycotide (400 mg thrice daily)
Trial: 20970833
Drug: Trospium XR
RxNorm normalized name: trospium Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trospium XR 60 mg
Trial: 11468201
Drug: Eptifibatide (180-microgram/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (180-microgram/kg bolus followed by 2 microgram/kg per minute infusion) with a second bolus of 90 microgram/kg
Trial: 11468201
Drug: Eptifibatide (250-microgram/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (250-microgram/kg bolus followed by 3 microgram/kg per minute infusion) with a second bolus of 125 microgram/kg
Trial: 10480221
Drug: 4 IU/m2/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 IU/m2/day of recombinant human growth hormone (rhGH)
Trial: 8067786
Drug: 2 IU/m2/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 IU/m2/day of recombinant human growth hormone (rhGH)
Trial: 8067786
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of rhGH
Trial: 8067786
Drug: 3 years
RxNorm normalized name: NanoVM 1-3 years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 years of rhGH treatment
Trial: 8067786
Drug: 1 year
RxNorm normalized name: COVID vacc 2024-2025 (5-11 years) (Pfizer)/PF 10 mcg/0.3 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 year of rhGH treatment
Trial: 3065157
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC three tablets at bedtime (81 mmol)
Trial: 3065157
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC three tablets in the morning plus three tablets at bedtime (bd) (162 mmol)
Trial: 2164771
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg at bedtime
Trial: 30744672
Drug: Sensory Integration
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sensory Integration Therapy (SIT)
Trial: 19289619
Drug: Capecitabine plus
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine plus trastuzumab (6 mg/kg body weight in 3-week cycles)
Trial: 19289619
Drug: Capecitabine (2,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (2,500 mg/m2 on days 1 through 14)
Trial: 11092994
Drug: Trandolapril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril (2 mg/day, n = 8)
Trial: 19210513
Drug: rizatriptan 5
RxNorm normalized name: rizatriptan 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rizatriptan 5 mg
Trial: 1347278
Drug: bismuth subsalicylate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bismuth subsalicylate, 600 mg three times daily (n = 19)
Trial: 1347278
Drug: ranitidine, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine, 300 mg at night (n = 20)
Trial: 25538330
Drug: Silodosin 8
RxNorm normalized name: silodosin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silodosin 8 mg once daily after dinner for 12 weeks
Trial: 25538330
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg controlled release once daily for 12 weeks
Trial: 11762414
Drug: Unlabeled antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unlabeled antibody therapy
Trial: 2252531
Drug: Time of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time of beginning immunotherapy after onset of diabetes
Trial: 908936
Drug: Bed rest
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bed rest (conservative treatment)
Trial: 31755989
Drug: Postoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative oral corticosteroids (OCS) in descending doses plus nasal douching over a period of 4 weeks
Trial: 3326525
Drug: Ketoconazole 800
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole 800 mg
Trial: 11304893
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose (HD, 7 mg/kg)
Trial: 3672322
Drug: Intermittent sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent sequential pneumatic compression alone
Trial: 18761644
Drug: Insulin detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin detemir (0.4 U/kg)
Trial: 9220210
Drug: Doxazosin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (mean final daily dose of 2.8 mg)
Trial: 8148213
Drug: Oily solution/suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oily solution/suspension in miglyol
Trial: 1421051
Drug: Teicoplanin 3
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 3 mg kg-1
Trial: 1421051
Drug: Teicoplanin 30
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 30 mg kg-1
Trial: 4082753
Drug: 16 microgram
RxNorm normalized name: Secretin 16 microgram powder for solution for injection vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 microgram dose of HBsAg vaccine
Trial: 29433376
Drug: Pomegranate polyphenol
RxNorm normalized name: Pomegranate Fruit Polyphenol Extract
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomegranate polyphenol supplementation (1 g of polyphenols, twice per day for one week)